Delisted
This security is no longer actively traded. Historical data is preserved for reference.No holders in 2025-Q4, no recent price data
ALLERGAN PLC
AGN·G0177J108·US·Common Stock·Unknown - Unknown
AGN (ALLERGAN PLC) is held by 0 institutional investors as of Q2 2020.
0
Holders
(22 Elite)
$0
Total Value
0%
Consensus
13F: Insider & Congress: Updated regularly
No verdict yet — fewer than 2 funds hold AGN.
Top Holders
Checking access…
Fund | Action | Shares | Value | Weight | Est. P&L | Conviction |
|---|---|---|---|---|---|---|
Exited | 0(-100.0%) | $11.8M | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $18.9M | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $204.3M | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $79.2M | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $95,000 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $17.9M | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $8.5M | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $12.5M | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $57.5M | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $708,000 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $42.5M | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $9.3M | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $5M | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $135.4M | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $4.7M | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $11M | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $12M | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $3.4M | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $7.4M | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $15.9M | 0.0% | — | 0 |
Showing 1-20 of 214
1 / 11
AGNALLERGAN PLCContinue exploring
Other Unknown stocks held by institutions
FISVFISERV INC324 holders · $20.7B
SPYSTATE STR SPDR S&P 500 ETF T286 holders · $340.8B
IVVISHARES TR252 holders · $559.6B
QQQINVESCO QQQ TR237 holders · $121.6B
IWMISHARES TR235 holders · $66.3B
VOOVANGUARD INDEX FDS235 holders · $261.4B
GLDSPDR GOLD TR228 holders · $32.8B
XLFSELECT SECTOR SPDR TR217 holders · $31.4B
XLESELECT SECTOR SPDR TR216 holders · $17.1B
EFAISHARES TR214 holders · $46.9B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer